Abstract
Case We describe a 55-year-old woman suffering from Sezary syndrome, had undergone chemotherapy consisting of cycles of cyclophosphamide and prednisone. 10 months later, she noticed a progressively increasing reticulated generalised pigmentation in the face, trunk and the extremities. Cylophosphamide was withdrawn. The hyperpigmentation began to clear slowly and gradually after 7 months. One year after cyclophosphamide withdrawal and facing the relapse of the disease, and its transformation to a large T cell lymphoma a mini CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone) protocol was held, leading to a remarkable aggravation of the pigmentation. Conclusion This adverse drug reaction to cyclophosphamide is peculiar by its localization and distribution and should be known in order not to confuse with other dermatosis.
This is a preview of subscription content, log in via an institution to check access.
References
Dutz JP, Ho VC. Immunosuppressives in dermatology. An update. Dermatol Clin. 1998;16:235–51.
Ranawaka RR. Patterns of chromonychia during chemotherapy in patients with skin type V and outcome after 1 year of follow-up. Clin Exp Dermatol. 2009;34:e920–6.
Srikanth M, Van Veen J, Raithatha A, Reilly JT. Cyclophosphamide-induced nail pigmentation. Br J Haematol. 2002;117:2.
Kumar S, Dixit R, Karmakar S, Paul S. Unusual nail pigmentation following cyclophosphamide-containing chemotherapy regimen. Indian J Pharmacol. 2010;42:243–4.
Dave S, Thappa DM. Peculiar pattern of nail pigmentation following cyclophosphamide therapy. Dermatol Online J. 2003;9:14.
Manigand G, Faux N, Dumas D, Taillandier J, Fixy P, Richerd F. Nail pigmentation during therapy with cyclophosphamide and doxorubicin. Sem Hop. 1983;59:1840–1.
Chittari K, Tagboto S, Tan BB. Cyclophosphamide-induced nail discoloration and skin hyperpigmentation: a rare presentation. Clin Exp Dermatol. 2009;34:405–6.
Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45.
Tobin DJ, Hagen E, Botchkarev VA, Paus R. Do hair bulb melanocytes undergo apoptosis during hair follicle regression (catagen)? J Invest Dermatol. 1998;111:941–7.
Singal R, Tunnessen WW Jr, Wiley JM, Hood AF. Discrete pigmentation after chemotherapy. Pediatr Dermatol. 1991;8:231–5.
Funding
None.
Conflicts of interest
None declared.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Youssef, M., Mokni, S., Belhadjali, H. et al. Cyclophosphamide-induced generalised reticulated skin pigmentation: a rare presentation. Int J Clin Pharm 35, 309–312 (2013). https://doi.org/10.1007/s11096-013-9756-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-013-9756-1